About turoctocog alfa
Recombinant factor VIII clotting factor
Used for
- Prevention and treatment of bleeding in haemophilia A
- Control of bleeding during surgery in haemophilia A
Usual adult dose
Intravenous dose is individualized by bleed severity, target factor VIII level, and response; often 20–50 IU/kg per dose.
Usual dose in children
Same individualized, weight-based approach as adults; dosing frequency depends on bleeding and response.
Common side effects
- Injection-site reactions
- Headache
- Fever
- Rash or itching
Important warnings
- Allergic reactions, including severe reactions, can occur.
- Factor VIII inhibitors may develop and reduce treatment effectiveness.
- Seek urgent care for signs of a serious allergic reaction.
- Dose and monitoring require specialist haemophilia care.
Pregnancy
Limited human data; use only when clinically needed, with specialist guidance.
Breastfeeding
Limited information; use requires assessment of clinical need and potential risks.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.